Speaker Details

Mona Shahriari, MD, FAAD

Mona Shahriari, MD, FAAD

SESSIONS

S039 Psoriasis: Modern Therapeutic Approaches
Mar 29, 2026 • 1:00 PM - 4:00 PM • Four Seasons 1
U076 From Hesitation to Confidence: Mastering Safe Prescribing in Inflammatory Skin Disorders
Mar 29, 2026 • 4:30 PM - 5:30 PM • Mile High 2B
F099 JAK Inhibitors in Dermatology: Identifying Ideal Candidates
Mar 30, 2026 • 3:30 PM - 5:30 PM • Mile High 2B

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences – Investigator(Grants/Research Funding), Speaker(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Janssen Biotech – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); LEO Pharma, US – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); National Psoriasis Foundation – Speaker/Faculty Education(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Consultant(Honoraria), Speaker(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);